Ikon aset - trading kripto, saham, dan emas di Pluang
Trading di Pluang
Satu platform untuk semua pasar
Download
Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Perbedaan Harga & Kinerja Arita Prima Indonesia Tbk (APII) vs UBC Medical Indonesia Tbk. (LABS)

Arita Prima Indonesia Tbk
UBC Medical Indonesia Tbk.

Kinerja harga

Pergerakan harga dalam 24 jam terakhir

Statistik utama

Perbedaan Arita Prima Indonesia Tbk dan UBC Medical Indonesia Tbk.: Arita Prima Indonesia Tbk diperdagangkan di Rp182 (kapitalisasi pasar 200,09 M, volume 24 jam 17,2 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp152 (kapitalisasi pasar 556,95 M, volume 24 jam 60,83 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Arita Prima Indonesia Tbk, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (60,83 jt vs 17,2 rb). Mana yang lebih baik tergantung tujuan investasimu.

APIILABS
Kapitalisasi Pasar
200,09 M556,95 M
Volume
17,2 rb60,83 jt
Lot
172608,34 rb
Perputaran
3,14 jt10,26 M
Harga Rata-rata
182,51168,64
Nilai Transaksi
3,14 jt10,26 M
Harga Ekuilibrium Indikatif
152
Volume Ekuilibrium Indikatif
4,52 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

APII
Lihat detail
LABS
Lihat detail

Tentang Arita Prima Indonesia Tbk

PT Arita Prima Indonesia Tbk (the Company) was established on October 5, 2000. Since its founding in 2000, the company initially marketed under the brand Arita valve products manufactured by Unimech Group, a multinational business group from Malaysia that specializes in construction services and valve manufacturers, as well as supporting products. The Company is the only company that was granted by the relevant manufacturers in the distribution and marketing in Indonesia, for valve products from leading manufacturers in the world with brands Arita from Malaysia, RK Marine from China, and KVC from Japan.

Selengkapnya di halaman APII

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS